Australia's Firebrick Pharma jumps on Singapore product launch
** Shares of Firebrick Pharma FRE.AX rise as much as 18.6%
to A$0.07, posting their biggest intraday percentage gain since
April 17
** Stock hits its highest level since May 27
** Pharmaceutical co launches its antiseptic nasal spray
Nasodine in Singapore
** About 294,000 shares change hands, compared with the
30-day average volume of around 129,000
** Stock up 18% YTD, based on last close
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement